scorecardresearch
Thursday, May 2, 2024
Support Our Journalism
HomeWorldPak: Severe shortage of life-saving drugs in Karachi worries patients, citizens

Pak: Severe shortage of life-saving drugs in Karachi worries patients, citizens

Follow Us :
Text Size:

Karachi [Pakistan], December 10 (ANI): Pakistan’s largest city, Karachi, is currently facing a severe shortage of essential medicines, including life-saving drugs, which has worried patients and citizens in the city, as reported by ARY News.

ARY News is a Pakistani news channel.

According to the report by ARY News, citing sources, Karachi and its residents are severely affected by a shortage of medicines, including vaccines, insulin for diabetes management, epilepsy drugs and several other products.

Meanwhile, medicines to control blood pressure and other life-saving drugs are being sold at high prices in the black market.

The shortage is causing severe problems for patients and citizens.

Moreover, the Drug Regulatory Authority of Pakistan (DRAP) launched a crackdown last month against an artificial shortage of life-saving medicines.

However, despite their action, the illegal sale of essential medicines continued, reported ARY News.

Additionally, the health authorities initiated the registration process for new life-saving drugs and also fastened the efforts to implement the plan for bringing other medicines back to the pharmacies.

Meanwhile, an alternative drug of some other medicine containing a rare formula has also been registered.

Last month, under the guidance of interim Health Minister Nadeem Jan, authorities have launched a crackdown on medicine profiteering across Pakistan.

During the operation in Lahore, significant measures were taken against those selling medicines above the approved prices, as reported by the spokesperson.

The crackdown revealed that Heparin injections, medications for tuberculosis, epilepsy, cancer, and life-saving drugs were being illicitly sold at prices exceeding the officially sanctioned rates, according to ARY News.

The spokesperson detailed instances of malpractice, stating that Tegeral, an epilepsy medicine, was being sold for Pakistani Rupee (PKR) 1300 to 1400 instead of the approved PKR 260 per box.

Minister Jan further asserted that the DRAP task force would take decisive action against individuals engaged in profiteering. “The task force of DRAP will take full action against the profiteers,” the minister added, according to ARY News. (ANI)

This report is auto-generated from ANI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular